Yes, melanoma can cause back pain, though it’s not from the skin cancer itself. Back pain becomes a concern when melanoma spreads (metastasizes) to the bones of the spine, which happens in roughly 3 to 7 percent of melanoma patients. Skeletal metastases account for about 17% of all metastases from advanced-stage melanoma, and the spine is one of the most common destinations: 70 to 86% of melanoma bone metastases target the axial skeleton, which includes the vertebrae, pelvis, and ribs.
How Melanoma Reaches the Spine
Melanoma cells can travel through the bloodstream and settle in bone tissue, where they disrupt normal bone health in a specific way. The cancer cells trigger a process called ferroptosis in osteocytes, the cells responsible for maintaining bone structure. Essentially, the melanoma forces bone cells to accumulate excess iron, which damages their protective membranes and kills them. As bone cells die off, the vertebrae weaken, and the growing tumor can press against nerves or the spinal cord itself.
This process can happen years after the original melanoma was treated. In one documented case, a 47-year-old man developed low back pain from a spinal melanoma 17 years after his primary tumor was completely removed surgically. That long latency period makes it important for melanoma survivors to take new or persistent back pain seriously, especially when it’s accompanied by fatigue or unexplained weight loss.
What This Back Pain Feels Like
Back pain from spinal metastases has several features that set it apart from a pulled muscle or a herniated disc. The most telling characteristic is pain that worsens at night. While most mechanical back pain improves when you lie down, cancer-related spinal pain often intensifies during rest. Pain that gets worse when you strain, cough, or bear down is another hallmark.
The pain is typically persistent and progressive, meaning it doesn’t come and go like a muscle spasm. It gradually worsens over weeks to months rather than flaring up after a specific injury. In the documented case above, the patient had three months of escalating low back pain along with fatigue and weight loss before being evaluated. On examination, his lumbar spine movement was very painful, with tenderness concentrated near the sacroiliac joint.
Red Flags That Need Urgent Attention
When a spinal tumor grows large enough to compress the spinal cord, the situation becomes a medical emergency. Spinal cord compression can cause permanent nerve damage if not treated quickly. The warning signs to watch for include:
- Limb weakness, particularly in the legs
- Difficulty walking or a change in your gait
- Numbness or tingling in the legs, feet, or trunk
- Loss of bladder or bowel control
- Pain in the thoracic (mid-back) or cervical (neck) spine that worsens with straining
Any combination of these symptoms in someone with a melanoma history warrants immediate evaluation. Progressive spinal cord compression typically presents as worsening myelopathy, a pattern where weakness and sensory loss creep upward or become more severe over days to weeks.
How Spinal Melanoma Is Diagnosed
No single imaging test can definitively confirm that a spinal lesion is melanoma. PET/CT scanning is generally the preferred first-line tool for evaluating suspected bone involvement, since it can detect metabolically active tumors throughout the body in a single session. MRI is particularly useful for evaluating how much a tumor is affecting the spinal cord and surrounding soft tissues. On MRI, melanoma lesions sometimes contain melanin pigment that creates a distinctive signal, but this feature is absent in most cases.
Because imaging alone can’t confirm the diagnosis, a biopsy is almost always necessary. Even when a patient has a known melanoma history and a suspicious-looking spinal lesion, tissue sampling is essential to rule out other possibilities and guide treatment decisions.
Treatment and Pain Relief
Stereotactic radiosurgery, a form of precisely targeted radiation, has become a primary treatment for melanoma that has spread to the spine. This matters because melanoma was historically considered resistant to conventional radiation therapy. The focused, high-dose approach of radiosurgery overcomes that resistance effectively.
The results are encouraging for pain control. In one series focused specifically on melanoma spinal metastases, 96% of patients experienced pain improvement and the local tumor control rate was 93%. Across all cancer types treated with spinal radiosurgery, pooled data from nearly 1,400 patients shows a 90% local control rate and a 79% pain improvement rate. About 40% of patients in some series achieved complete pain resolution. The risk of spinal cord damage from the procedure itself is very low, under 0.5%.
Immunotherapy drugs that activate the immune system against cancer cells are also a mainstay of advanced melanoma treatment. These treatments can sometimes cause their own musculoskeletal side effects, including joint pain and general muscle aches, which can occasionally overlap with or be mistaken for pain from metastatic disease. These immune-related side effects are not yet well characterized, partly because they’re inconsistently reported in clinical trials.
Back Pain as a Treatment Side Effect
It’s worth noting that back pain in a melanoma patient doesn’t always mean the cancer has spread to the spine. Checkpoint inhibitor immunotherapy, the class of drugs most commonly used for advanced melanoma, can trigger inflammatory reactions throughout the body. Some patients develop arthritis-like symptoms, muscle inflammation, or generalized musculoskeletal pain as a side effect of treatment. These immune-related reactions behave differently from typical rheumatologic conditions, making them tricky to diagnose. The distinction between treatment-related pain and metastatic pain is important because the management differs significantly.
The Broader Outlook
The prognosis for metastatic melanoma remains serious. The five-year survival rate for stage IV melanoma ranges from about 5 to 19%, depending on where the cancer has spread and how many sites are involved. Median overall survival after distant metastases develop has been reported at around 5 months, though newer immunotherapy and targeted therapy options have improved outcomes for many patients beyond what older statistics reflect.
For melanoma survivors experiencing new, persistent, or worsening back pain, particularly pain that disrupts sleep, comes with unexplained weight loss, or is accompanied by any neurological changes, prompt evaluation can make a meaningful difference. Early detection of spinal metastases opens the door to treatments that effectively control pain and preserve neurological function in the vast majority of cases.